Dodds Ashley, E. S., A. K. Zaas, A. F. Fang, B. Damle, and J. R. Perfect. “Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets.” Antimicrob Agents Chemother 51, no. 3 (March 2007): 877–80. https://doi.org/10.1128/AAC.01263-06.
Zaas, Aimee K., Elizabeth S. Dodds Ashley, Barbara D. Alexander, Melissa D. Johnson, and John R. Perfect. “Caspofungin for invasive candidiasis at a tertiary care medical center.” Am J Med 119, no. 11 (November 2006): 993.e1-993.e6. https://doi.org/10.1016/j.amjmed.2006.02.029.
Ashley, E. S. D., R. Lewis, J. S. Lewis, C. Martin, and D. Andes. “Pharmacology of systemic antifungal agents.” Clinical Infectious Diseases 43, no. SUPPL. 1 (August 1, 2006). https://doi.org/10.1086/504492.
Dodds Ashley, Elizabeth S. “Treatment options for invasive fungal infections.” In Pharmacotherapy, 26:55S-60S, 2006. https://doi.org/10.1592/phco.26.6part2.55S.
Alexander, Barbara D., Elizabeth Dodds Ashley, L Barth Reller, and Shelby D. Reed. “Cost savings with implementation of PNA FISH testing for identification of Candida albicans in blood cultures.” Diagn Microbiol Infect Dis 54, no. 4 (April 2006): 277–82. https://doi.org/10.1016/j.diagmicrobio.2005.10.011.
Alexander, B. D., E. S. Dodds Ashley, R. M. Addison, J. A. Alspaugh, N. J. Chao, and J. R. Perfect. “Non-comparative evaluation of the safety of aerosolized amphotericin B lipid complex in patients undergoing allogeneic hematopoietic stem cell transplantation.” Transpl Infect Dis 8, no. 1 (March 2006): 13–20. https://doi.org/10.1111/j.1399-3062.2006.00125.x.
Hickey, Anthony J., Dongmei Lu, Elizabeth Dodds Ashley, and Jason Stout. “Inhaled azithromycin therapy.” J Aerosol Med 19, no. 1 (2006): 54–60. https://doi.org/10.1089/jam.2006.19.54.
Dodds Ashley, Elizabeth S., and Barbara D. Alexander. “Posaconazole.” Drugs Today (Barc) 41, no. 6 (June 2005): 393–400. https://doi.org/10.1358/dot.2005.41.6.898145.
Perfect, John R., Elizabeth Dodds Ashley, and Richard Drew. “Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients.” Clin Infect Dis 39 Suppl 4 (October 15, 2004): S207–10. https://doi.org/10.1086/421958.
Dodds Ashley, E. S., D. N. Carroll, J. J. Engemann, A. D. Harris, V. G. Fowler, D. J. Sexton, and K. S. Kaye. “Risk factors for postoperative mediastinitis due to methicillin-resistant Staphylococcus aureus.” Clin Infect Dis 38, no. 11 (June 1, 2004): 1555–60. https://doi.org/10.1086/420819.